title: PspA family fusion proteins delivered by attenuated Salmonella enterica serovar Typhimurium extend and enhance protection against Streptococcus pneumoniae.
abstract: Pneumococcal surface protein A (PspA) is highly immunogenic and can induce a protective immune response against pneumococcal infection. PspA is divided into two major families based on serological variability: family 1 and family 2. To provide broad protection, PspA proteins from pneumococcal strains Rx1 (family 1) and EF5668 (family 2) were combined to form two PspA fusion proteins, PspA/Rx1-EF5668 and PspA/EF5668-Rx1. Each protein was fused to a type II secretion signal and delivered by a recombinant attenuated Salmonella vaccine (RASV). Both PspA/Rx1-EF5668 and PspA/EF5668-Rx1 were synthesized in the RASV and secreted into the periplasm and supernatant. The fusion proteins reacted strongly with both anti-PspA/Rx1 and anti-PspA/EF5668 antisera. Oral immunization of BALB/c mice with RASV synthesizing either PspA fusion protein elicited serum immunoglobulin G (IgG) and mucosal IgA responses against both families of PspA. Analysis of IgG isotypes (IgG2a and IgG1) indicated a strong Th1 bias to the immune responses to both proteins. Sera from mice immunized with RASV synthesizing PspA/Rx1-EF5668 bound to the surface and directed C3 complement deposition on representative strains from all five PspA clades. Immunization with RASV synthesizing either protein protected mice against intraperitoneal challenge with Streptococcus pneumoniae WU2 strain (family 1), intravenous challenge with S. pneumoniae 3JYP2670 strain (family 2), and intranasal challenge with S. pneumoniae A66.1 (family 1). The PspA/Rx1-EF5668 protein elicited significantly greater protection than PspA/EF5668-Rx1, PspA/Rx1, or PspA/EF5668. These results indicate an RASV synthesizing a PspA fusion protein representing both PspA families constitutes an effective antipneumococcal vaccine, extending and enhancing protection against multiple strains of S. pneumoniae.
authors.affiliation: The Biodesign Institute, Center for Infectious Diseases and Vaccinology, Arizona State University. P.O. Box 875401, 1001 S. McAllister Ave., Tempe, AZ 85287-5401, USA. wie.xin@asu.edu
authors.forename: Wei
authors.initials: W
authors.lastname: Xin
authors.forename: Yuhua
authors.initials: Y
authors.lastname: Li
authors.forename: Hua
authors.initials: H
authors.lastname: Mo
authors.forename: Kenneth L
authors.initials: KL
authors.lastname: Roland
authors.forename: Roy
authors.initials: R
authors.lastname: Curtiss
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood; D001426:Bacterial Proteins / Q000235:genetics / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005822:Genetic Vectors; D006801:Humans; D018928:Immunity, Mucosal; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000097:blood; D051379:Mice; D008807:Mice, Inbred BALB C; D011008:Pneumococcal Infections / Q000276:immunology / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology*; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000276:immunology; D012486:Salmonella typhimurium / Q000235:genetics*; D013296:Streptococcus pneumoniae / Q000235:genetics / Q000276:immunology*; D016019:Survival Analysis
chemical_list: D000907:Antibodies, Bacterial; D001426:Bacterial Proteins; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D022242:Pneumococcal Vaccines; D011993:Recombinant Fusion Proteins; C051592:pneumococcal surface protein A
references.citation: Infect Immun. 2007 Nov;75(11):5460-4
references.pmid: 17698570
references.citation: Adv Exp Med Biol. 1989;251:33-47
references.pmid: 2692430
references.citation: Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):593-8
references.pmid: 19114649
references.citation: Infect Immun. 2001 Apr;69(4):2154-61
references.pmid: 11254570
references.citation: J Clin Microbiol. 2003 Jan;41(1):386-92
references.pmid: 12517877
references.citation: J Med Microbiol. 2009 Jan;58(Pt 1):101-104
references.pmid: 19074659
references.citation: Infect Immun. 2000 Oct;68(10):5889-900
references.pmid: 10992499
references.citation: J Bacteriol. 1951 Sep;62(3):293-300
references.pmid: 14888646
references.citation: Infect Immun. 2004 Jan;72(1):114-22
references.pmid: 14688088
references.citation: Infect Immun. 2002 Apr;70(4):1739-49
references.pmid: 11895935
references.citation: J Clin Microbiol. 2000 Oct;38(10):3663-9
references.pmid: 11015380
references.citation: Infect Immun. 2009 May;77(5):2076-83
references.pmid: 19255193
references.citation: J Infect Dis. 2000 Dec;182(6):1694-701
references.pmid: 11069242
references.citation: Infect Immun. 1990 Oct;58(10):3293-9
references.pmid: 1698178
references.citation: J Bacteriol. 1965 Nov;90(5):1238-50
references.pmid: 5321479
references.citation: Infect Immun. 2008 Nov;76(11):5305-9
references.pmid: 18779338
references.citation: Infect Immun. 2008 Jul;76(7):3241-54
references.pmid: 18458067
references.citation: FEMS Immunol Med Microbiol. 2003 Jul 15;37(2-3):99-104
references.pmid: 12832112
references.citation: Infect Immun. 2007 Dec;75(12):5930-8
references.pmid: 17923518
references.citation: J Infect Dis. 1977 Dec;136(6):733-9
references.pmid: 925381
references.citation: Infect Immun. 1994 Dec;62(12):5683-8
references.pmid: 7960154
references.citation: Philos Trans R Soc Lond B Biol Sci. 1999 Apr 29;354(1384):777-85
references.pmid: 10365403
references.citation: Pediatr Infect Dis J. 2000 Apr;19(4):388-93
references.pmid: 10783041
references.citation: Infect Immun. 2001 Nov;69(11):6604-11
references.pmid: 11598028
references.citation: Microb Drug Resist. 1997 Winter;3(4):401-8
references.pmid: 9442494
references.citation: JAMA. 2004 Aug 11;292(6):716-20
references.pmid: 15304469
references.citation: Eur Cytokine Netw. 2003 Jul-Sep;14(3):186-91
references.pmid: 14656695
references.citation: Eur J Immunol. 1979 Apr;9(4):255-61
references.pmid: 89033
references.citation: Infect Immun. 2003 Mar;71(3):1033-41
references.pmid: 12595413
references.citation: Infect Immun. 1998 Aug;66(8):3744-51
references.pmid: 9673257
references.citation: Proc Natl Acad Sci U S A. 2005 Mar 29;102(13):4848-53
references.pmid: 15781870
references.citation: J Bacteriol. 1992 Jan;174(2):601-9
references.pmid: 1729249
references.citation: Anal Biochem. 1976 Jul;74(1):160-70
references.pmid: 786067
references.citation: Vaccine. 1996 Jun;14(9):858-67
references.pmid: 8843627
references.citation: Gene. 1990 Sep 28;94(1):29-35
references.pmid: 2227450
references.citation: Med Microbiol Immunol. 1999 May;187(4):191-8
references.pmid: 10363675
references.citation: Vaccine. 2007 Jan 22;25(6):1030-5
references.pmid: 17084949
references.citation: J Med Microbiol. 2006 Feb;55(Pt 2):215-221
references.pmid: 16434715
references.citation: Infect Immun. 2008 Nov;76(11):5238-46
references.pmid: 18765737
references.citation: Eur J Immunol. 2006 Jan;36(1):46-57
references.pmid: 16342325
references.citation: Infect Immun. 2001 Aug;69(8):4870-3
references.pmid: 11447162
references.citation: Trends Cell Biol. 2000 Dec;10(12):542-50
references.pmid: 11121747
references.citation: Vaccine. 2008 Jul 4;26(29-30):3765-71
references.pmid: 18513840
references.citation: Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16969-74
references.pmid: 12477926
references.citation: Vaccine. 1998 Jan-Feb;16(2-3):286-92
references.pmid: 9607044
references.citation: Infect Immun. 2001 Nov;69(11):6718-24
references.pmid: 11598043
references.citation: Lancet. 2000 Oct 7;356(9237):1210-1
references.pmid: 11072934
references.citation: Clin Vaccine Immunol. 2008 Mar;15(3):499-505
references.pmid: 18184825
references.citation: Infect Immun. 2007 Jan;75(1):350-7
references.pmid: 17088353
references.citation: J Infect Dis. 2005 Dec 1;192(11):1996-2003
references.pmid: 16267773
references.citation: Vaccine. 2005 May 25;23(28):3697-703
references.pmid: 15882530
references.citation: Infect Immun. 1999 Sep;67(9):4720-4
references.pmid: 10456922
references.citation: Vaccine. 2000 Dec 8;19 Suppl 1:S87-95
references.pmid: 11163470
references.citation: Eur J Clin Microbiol Infect Dis. 2007 Oct;26(10):739-42
references.pmid: 17665229
references.citation: Mol Immunol. 2003 Sep;40(2-4):95-107
references.pmid: 12914816
references.citation: J Infect Dis. 2007 Nov 15;196(10):1528-36
references.pmid: 18008233
references.citation: Infect Immun. 1999 Dec;67(12):6533-42
references.pmid: 10569772
references.citation: JAMA. 2007 Apr 25;297(16):1784-92
references.pmid: 17456820
references.citation: J Infect Dis. 1997 Apr;175(4):839-46
references.pmid: 9086139
references.citation: Clin Infect Dis. 2001 Jan;32(1):76-102
references.pmid: 11118387
references.citation: J Clin Invest. 1999 Oct;104(8):1139-47
references.pmid: 10525053
references.citation: Clin Vaccine Immunol. 2008 Oct;15(10):1529-35
references.pmid: 18753341
references.citation: J Immunol. 1979 May;122(5):1892-8
references.pmid: 448111